Abstract
Tattoos are becoming increasingly common and are the result of a variety of underlying motivations. Patients with medical or skin conditions should be advised of the tattooing-related risks and recommendations specific for their condition. Tattooing is strictly contraindicated in only a few medical/skin conditions (i.e. pregnancy, breastfeeding, severe immunosuppression, tumour-related scars). In other medical/skin conditions, tattoo-related risks should be considered and recommendations and precautions followed.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Kluger N, De Cuyper C. A practical guide about tattooing in patients with chronic skin disorders and other medical conditions. Am J Cllin Dermatol. 2018;19(2):167–80.
Wohlrab S, Stahl J, Kappeler PM. Modifying the body: motivations for getting tattooed and pierced. Body Image. 2007;4(1):87–95.
Vassileva S, Hristakieva E. Medical applications of tattooing. Clin Dermatol. 2007;25(4):367–74.
Drost BH, van de Langenberg R, Manusama OR, et al. Dermatography (medical tattooing) for scars and skin grafts in head and neck patients to improve appearance and quality of life. JAMA Facial Plast Surg. 2017;19(1):16–22.
Kluger N, Aldasouqi S. The motivations and benefits of medical alert tattoos in patients with diabetes. Endocr Pract. 2013;19(2):373–6.
Kluger N, Aldasouqi S. A new purpose for tattoos: medical alert tattoos. Presse Med. 2013;42(2):134–7.
Laux P, Tralau T, Tentschert J, et al. A medical-toxicological view of tattooing. Lancet. 2016;387(10016):395–402.
Kluger N. Contraindications for tattooing. Curr Probl Dermatol. 2015;48:76–87.
Wollina U. Severe adverse events related to tattooing: an retrospective analysis of 11 years. Indian J Dermatol. 2012;57(6):439–43.
Simunovic C, Shinohara MM. Complications of decorative tattoos: recognition and management. Am J Clin Dermatol. 2014;15(6):525–36.
Kluger N. Cutaneous and systemic complications associated with tattooing. Presse Med. 2016;45(6 Pt 1):567–76.
Jafari S, Buxton JA, Afshar K, et al. Tattooing and risk of hepatitis B: a systematic review and meta-analysis. Can J Public Health. 2012;103(3):207–12.
Jafari S, Copes R, Baharlou S, et al. Tattooing and the risk of transmission of hepatitis C: a systematic review and meta-analysis. Int J Infect Dis. 2010;14:e928–40.
Kluger N. Can a mother get a tattoo during pregnancy or while breastfeeding? [letter]. Eur J Obstet Gynecol Reprod Biol. 2012;161(2):234–5.
Kluger N. Tattooing and piercing: an underestimated issue for immunocompromised patients? Presse Med. 2013;42(5):791–4.
Kluger N. Tattooing and immunodepression: caution is warranted also in organ transplant patients. Transpl Infect Dis. 2017. https://doi.org/10.1111/tid.12701.
Author information
Authors and Affiliations
Consortia
Ethics declarations
Conflict of interest
The article was adapted from the American Journal of Clinical Dermatology, 2018;19(2):167-80 [1] by employees of Adis/Springer, who are responsible for the article content and declare no conflicts of interest.
Funding
The preparation of this review was not supported by any external funding.
Rights and permissions
About this article
Cite this article
Adis Medical Writers. Tattooing is possible in many patients with medical or skin conditions as long as disease-specific recommendations are followed. Drugs Ther Perspect 34, 425–428 (2018). https://doi.org/10.1007/s40267-018-0533-z
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40267-018-0533-z